Cost-effectiveness analysis of sunitinib in patients with metastatic and/or unresectable gastrointestinal stroma tumours (GIST) after progression or intolerance with imatinib

  1. Paz-Ares, L.
  2. García Del Muro, X.
  3. Grande, E.
  4. González, P.
  5. Brosa, M.
  6. Díaz, S.
Aldizkaria:
Clinical and Translational Oncology

ISSN: 1699-048X,  1699-3055

Argitalpen urtea: 2008

Alea: 10

Zenbakia: 12

Orrialdeak: 831-839

Mota: Artikulua

DOI: 10.1007/S12094-008-0297-3 GOOGLE SCHOLAR

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus